$106.36
-0.690 (-0.645%)
At Close: Jun 16, 2026
Oppenheimer's Brian Nagel on Home Depot Q3 results: Largely a weather-driven sales upside
08:57am, Tuesday, 12'th Nov 2024
Brian Nagel, Oppenheimer senior analyst, joins 'Squawk Box' to break down Home Depot's Q3 earnings results.
Vor Bio price target lowered to $8 from $10 at Oppenheimer
02:27pm, Friday, 08'th Nov 2024
Oppenheimer analyst Matthew Biegler lowered the firm's price target on Vor Bio to $8 from $10 and keeps an Outperform rating on the shares following the Q3 report. The firm cites updated spending esti
Call of the Day: Oppenheimer raises bank targets
02:12pm, Tuesday, 05'th Nov 2024
The Investment Committee debate the big bank names.
Oppenheimer Holdings: Mid-Market Prevailing In Capital Markets, Solid All Around
09:10am, Saturday, 26'th Oct 2024
Oppenheimer's earnings report show strength in mid-market capital markets franchise as well as solid growth in the rest of its AUM and commission based businesses. Risk taking in public markets has dr
Oppenheimer Holdings Inc. Reports Third Quarter 2024 Earnings
08:00am, Friday, 25'th Oct 2024
NEW YORK , Oct. 25, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $24.5 million or $2.38 basic earnings per share for the third quart
Oppenheimer Hires Christian Baetz As Managing Director, Consumer Investment Banking
06:00am, Tuesday, 15'th Oct 2024
NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today th
Oppenheimer downgrades Microsoft: OpenAI losses are not properly priced in
12:30pm, Tuesday, 08'th Oct 2024
Timothy Horan, Oppenheimer managing director and senior analyst, joins 'Money Movers' to discuss the firm's downgrade of Microsoft's stock.
SEATTLE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced tre
Oppenheimer Names Todd Wiggins Regional Director of Dallas-Fort Worth Region
06:00am, Tuesday, 01'st Oct 2024
Industry Veteran to Bring His Experience Leading, Attracting, and Retaining Advisors to His New Location NEW YORK , Oct. 1, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading we
Nike has to get back on its product innovation game, says Oppenheimer's Brian Nagel
05:13pm, Friday, 27'th Sep 2024
Brian Nagel, Oppenheimer Senior Analyst, joins 'Closing Bell: Overtime' to discuss his look ahead to Nike next week.
Oppenheimer Expands Presence in Tennessee with the Opening of its Memphis Office
06:00am, Monday, 23'rd Sep 2024
Latest Move into Tennessee Builds on Firm's Momentum Following the Opening of Its Nashville Office in 2022 NEW YORK , Sept. 23, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading
Nike CEO change is a 'step in the right direction,' says Oppenheimer's Brian Nagel
03:14pm, Friday, 20'th Sep 2024
Brian Nagel, Oppenheimer & Co. senior analyst, joins CNBC's 'Power Lunch' to discuss what Nike's leadership change could mean for the company, the path forward for the stock, and more.
OPPENHEIMER HOLDINGS INC. ANNOUNCES REDEMPTION OF $113 MILLION OF 5.50% SENIOR SECURED NOTES DUE 2025
09:00am, Thursday, 19'th Sep 2024
NEW YORK , Sept. 19, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (the "Company" or "Oppenheimer") today announced that it has delivered to the holders of its 5.50% Senior Secured Notes due 2025 (the
Oppenheimer Names Aaron Stowell Managing Director and Branch Manager of Atlanta Office
07:00am, Tuesday, 10'th Sep 2024
Longtime financial services veteran assumes role after serving in similar position for 17 years NEW YORK , Sept. 10, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading wealth ma
Mark J. Hovanic Joins Oppenheimer as Executive Director and Branch Manager
06:00am, Tuesday, 03'rd Sep 2024
Former J.P. Morgan Securities Veteran to Lead Firm's Richmond and Virginia Beach Offices NEW YORK , Sept.
Sign In
Buy OPY